診療准教授　今村有佑　（千葉大学大学院医学研究院泌尿器科学・千葉大学医学部附属病院泌尿器科）

HOME　>　共通メニュー　>教室員紹介　>　診療准教授　今村有佑

診療准教授　今村有佑

Yusuke Imamura

2004年	千葉大学医学部　卒業
2004年	国立精神・神経センター国府台病院　初期研修医
2006年	千葉大学医学部附属病院　泌尿器科　後期研修医
2007年	千葉県がんセンター　泌尿器科　医員
2009年	千葉大学医学部附属病院　泌尿器科　医員
2012年	千葉県がんセンター　泌尿器科　医員
2013年	千葉大学大学院医学薬学府博士課程（先進医療科学専攻泌尿器科学）修了学位（医学博士号）取得
2013年	BC Cancer Agency Genome Sciences Centre (Canada) 博士研究員
2016年	千葉大学医学部附属病院　泌尿器科　助教
2020年	千葉大学医学部附属病院　泌尿器科　講師
2024年	千葉大学医学部附属病院　泌尿器科　診療准教授
現在に至る

・日本泌尿器科学会 (専門医・指導医)
・日本泌尿器内視鏡・ロボティクス学会（泌尿器科腹腔鏡技術認定医）
・日本内視鏡外科学会（泌尿器科腹腔鏡技術認定医）
・日本内分泌学会内分泌代謝科（泌尿器科）専門医
・日本内分泌外科学会
・日本癌治療学会
・日本泌尿器分子・細胞研究会
・日本尿路結石症学会
・日本泌尿器腫瘍学会
・日本アンドドロジー学会
・日本人類遺伝学会
・日本遺伝性腫瘍学会
・Society for Basic Urologic Research（SBUR）
・米国泌尿器科学会（AUA）

・泌尿器科一般
・泌尿器腫瘍学（前立腺癌、副腎腫瘍）

・2013年　千葉大学大学院医学研究院泌尿器科同門会学術奨励島崎賞
・2017年　International Uro-Oncological Symposium in Taiwan Best E-poster Award

・科学研究費助成金　若手研究スタート支援　平成28年 - 平成29年度
・科学研究費助成金　若手研究（B）　平成29年度 - 平成31年度
・科学研究費助成金　基盤研究（C）　令和2年度 - 令和4年度
・科学研究費助成金　基盤研究（C）　令和6年度 - 令和8年度

・前立腺癌における新規薬剤の解明

1.	Suyama T, Ueda T, Fukasawa S, Imamura Y, Nakamura K, Miyasaka K, Sazuka T, Egoshi K, Nihei N, Hamano M, Ichikawa T, Maruoka M. Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma. Jpn J Clin Oncol. 2009 Apr;39(4):244-50.
2.	Ueda T, Imamura Y, Komaru A, Fukasawa S, Sazuka T, Suyama T, Naya Y, Nihei N, Ichikawa T, Maruoka M. Treatment outcomes of sorafenib for first line or cytokinerefractory advanced renal cell carcinoma in Japanese patients. Int J Urol. 2010 Sep;17(9):811-5.
3.	Imamura Y, Sakamoto S, Endo T, Utsumi T, Fuse M, Suyama T, Kawamura K, Imamoto T, Yano K, Uzawa K, Nihei N, Suzuki H, Mizokami A, Ueda T, Seki N, Tanzawa H, Ichikawa T. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway. PLoS One. 2012;7(8):e42456.
4.	Imamura Y, Kawamura K, Sazuka T, Sakamoto S, Imamoto T, Nihei N, Suzuki H, Okano T, Nozumi K, Ichikawa T. Development of a nomogram for predicting the stone-free rate after transurethral ureterolithotripsy using semi-rigid ureteroscope. Int J Urol. 2013 Jun;20(6):616-21.
5.	Utsumi T, Suyama T, Imamura Y, Fuse M, Sakamoto S, Nihei N, Ueda T, Suzuki H, Seki N, Ichikawa T. The association of CXCR3 and renal cell carcinoma metastasis. J Urol. 2014 Aug;192(2):567-74.
6.	Namekawa T, Fukasawa S, Komaru A, Kobayashi M, Imamura Y, Ohzeki T, Takagi K, Sato Y, Akakura K, Ichikawa T, Ueda T. Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events. Int J Clin Oncol. 2015 Dec;20(6):1185-91.
7.	Kato M, Banuelos CA, Imamura Y, Leung JK, Caley DP, Wang J, Mawji NR, Sadar MD. Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer. Clin Cancer Res. 2015 Dec 28.
8.	Imamura Y, Tien AH, Pan J, Leung JK, Banuelos CA, Jian K, Wang J, Mawji NR, Fernandez JG, Lin KS, Andersen RJ, Sadar MD. An imaging agent to detect androgen receptor and its active splice variants in prostate cancer. JCI Insight. 2016 Jul 21.
9.	Banuelos CA, Tavakoli I, Tien AH, Caley DP, Mawji NR, Li Z, Wang J, Yang YC, Imamura Y, Yan L, Wen JG, Andersen RJ, Sadar MD. Sintokamide A is a Novel Antagonist of Androgen Receptor that Uniquely Binds Activation Function-1 in its Amino-Terminal Domain. J Biol Chem. 2016 Aug 30.
10.	Nakamura K, Goto Y, Sazuka T, Imamura Y, Komiya A, Ichikawa T. [KOUJIN POWDER (RED GINSENG POWDER) WITH NINJIN-YOUEITO FOR FATIGUE DUE TO TARGETED THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A RETROSPECTIVE COHORT STUDY]. Nihon Hinyokika Gakkai Zasshi. 2017;108(4):194-199.
11.	Takei A, Sakamoto S, Wakai K, Tamura T, Imamura Y, Xu M, Maimaiti M, Kawamura K, Imamoto T, Komiya A, Akakura K, Ichikawa T. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy. Int J Urol. 2018 Apr 25 (4):352-358.
12.	Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical?Prostatectomy. Clin Genitourin Cancer. 2018 Feb 24 (4): e817-e829.
13.	Sugiura M, Imamura Y, Kawamura K, Yamamoto S, Sazuka T, Nakamura K, Sakamoto S, Nagano H, Koide H, Tanaka T, Imamoto T, Komiya A, Ichikawa T. Contralateral adrenal width predicts the duration of prolonged post-surgical steroid replacement for subclinical Cushing syndrome. Int J Urol. 2018 Jun;25(6):583-588.
14.	Yamamoto S, Sakamoto S, Imamura Y, Sazuka T, Nakamura K, Inoue T, Chiba K, Miyazaki K, Inoue A, Nagata M, Ichikawa T. Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma. Int J Urol. 2019 Aug;26(8):791-796.
15.	Sazuka T, Sakamoto S, Nakamura K, Imamura Y, Yamamoto S, Komiya A, Ichikawa T. Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Int J Urol. 2019 Dec;26(12):1106-1112.
16.	Higuchi K, Sakamoto S, Ando K, Maimaiti M, Takeshita N, Okunushi K, Reien Y, Imamura Y, Sazuka T, Nakamura K, Matsushima J, Furihata T, Ikehara Y, Ichikawa T, Anzai N. Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma. Sci Rep. 2019 Nov 20;9(1):16776.
17.	Ando K, Sakamoto S, Takeshita N, Fujimoto A, Maimaiti M, Saito S, Sanjyon P, Imamura Y, Sato N, Komiya A, Akakura K, Ichikawa T. Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel. Prostate. 2020 Feb;80(3):247-255.
18.	Maimaiti M, Sakamoto S, Yamada Y, Sugiura M, Rii J, Takeuchi N, Imamura Y, Furihata T, Ando K, Higuchi K, Xu M, Sazuka T, Nakamura K, Kaneda A, Kanai Y, Kyprianou N, Ikehara Y, Anzai N, Ichikawa T. Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma. Sci Rep. 2020 Jan 28;10(1):1292.
19.	Yamada Y, Sakamoto S, Rii J, Yamamoto S, Kamada S, Imamura Y, Nakamura K, Komiya A, Nakatsu H, Ichikawa T. How many bone metastases may be defined as high-volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study. Prostate. 2020 Apr;80(5):432-440.
20.	Nakamura K, Imamura Y, Yamamoto S, Sazuka T, Sakamoto S, Ichikawa T. Soft coagulation in robot-assisted partial nephrectomy without renorrhaphy: Comparison with standard suture. Int J Urol. 2020 Apr;27(4):352-354.
21.	Yamada Y, Sakamoto S, Rii J, Yamamoto S, Kamada S, Imamura Y, Nakamura K, Komiya A, Nakatsu H, Ichikawa T. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer. Prostate. 2020 May;80(7):559-569.
22.	Rii J, Sakamoto S, Yamada Y, Takeshita N, Yamamoto S, Sazuka T, Imamura Y, Nakamura K, Komiya A, Komaru A, Fukasawa S, Nakatsu H, Akakura K, Ichikawa T. Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients. Prostate. 2020 Aug;80(11):850-858.
23.	Sazuka T, Sakamoto S, Imamura Y, Nakamura K, Yamamoto S, Arai T, Takeuchi N, Komiya A, Teishima J, Ichikawa T. Relationship between post-void residual urine volume, preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma. Int J Urol. 2020 Nov;27(11):1024-1030.
24.	Sugiura M, Sato H, Okabe A, Fukuyo M, Mano Y, Shinohara KI, Rahmutulla B, Higuchi K, Maimaiti M, Kanesaka M, Imamura Y, Furihata T, Sakamoto S, Komiya A, Anzai N, Kanai Y, Luo J, Ichikawa T, Kaneda A. Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer. Transl Oncol. 2021 Jan;14(1):100915.
25.	Sato H, Imamura Y, Sakamoto S, Sugiura M, Arai T, Yamamoto S, Takeuchi N, Sazuka T, Nakamura K, Nagano H, Koide H, Tanaka T, Komiya A, Ichikawa T. Adrenalectomy in Japanese patients with subclinical Cushing syndrome: 1-mg dexamethasone suppression test to predict the surgical benefit. Int J Urol. 2021 Mar;28(3):273-279.
26.	Ando K, Sakamoto S, Saito S, Maimaiti M, Imamura Y, Sazuka T, Sato N, Komiya A, Anzai N, Ichikawa T. Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel. Cancers (Basel). 2021 Feb 12;13(4):773.
27.	Leung JK, Imamura Y, Kato M, Wang J, Mawji NR, Sadar MD. Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor. Commun Biol. 2021 Mar 22;4(1):381.
28.	Ishiwata K, Suzuki S, Igarashi K, Ruike Y, Naito K, Ishida A, Deguchi-Horiuchi H, Fujimoto M, Koide H, Imamura Y, Sakamoto S, Ichikawa T, Ikeda JI, Yokote K. Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation. Eur J Endocrinol. 2021 Jun 5;185(1):155-165.
29.	Rii J, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Yamada Y, Maimaiti M, Ando K, Wakai K, Xu M, Imamura Y, Shindo N, Hirota T, Kaneda A, Kanai Y, Ikehara Y, Anzai N, Ichikawa T. Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor. Cancer Sci. 2021 Sep;112(9):3871-3883.
30.	Maimaiti M, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Matsusaka K, Xu M, Ando K, Saito S, Wakai K, Imamura Y, Nakayama K, Kanai Y, Kaneda A, Ikehara Y, Ikeda JI, Anzai N, Ichikawa T. The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2. Sci Rep. 2021 Jun 1;11(1):11478.
31.	Arai T, Takeuchi N, Sazuka T, Sato H, Imamura Y, Sakamoto S, Komiya A, Ichikawa T. Successful treatment of metastatic bladder cancer by gemcitabine-cisplatin re-challenge after pembrolizumab. IJU Case Rep. 2021 Jul 20;4(6):360-362.
32.	Kanesaka M, Sakamoto S, Yamada Y, Rii J, Maimaiti M, Sazuka T, Imamura Y, Komiya A, Akakura K, Ikehara Y, Nakatsu H, Ichikawa T. Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients. Prostate Int. 2021 Dec;9(4):208-214.
33.	Arai T, Sazuka T, Sato H, Imamura Y, Sakamoto S, Ichikawa T. Efficacy of photodynamic diagnosis-assisted transurethral resection of bladder tumor for T1 bladder cancer: Novel second transurethral resection initiatives utilizing photodynamic diagnosis. Int J Urol. 2022 Oct;29(10):1238-1240.
34.	Pae S, Sakamoto S, Zhao X, Saito S, Tamura T, Imamura Y, Sazuka T, Reien Y, Hirayama Y, Hashimoto H, Kanai Y, Ichikawa T, Anzai N. Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective. J Pharmacol Sci. 2022 Dec;150(4):251-258.
35.	Baba H, Sakamoto S, Zhao X, Yamada Y, Rii J, Fujimoto A, Kanesaka M, Takeuchi N, Sazuka T, Imamura Y, Akakura K, Ichikawa T. Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer. Cancers (Basel). 2022 Nov 25;14(23):5823.?
36.	Takeshita N, Sakamoto S, Yamada Y, Sazuka T, Imamura Y, Komiya A, Akakura K, Sato N, Nakatsu H, Kato T, Sugimoto M, Tsuzuki T, Ichikawa T. Detection of intraductal carcinoma in prostate cancer patients with small tumor volume. Prostate. 2023 May;83(6):580-589.
37.	Tsukamoto R, Sazuka T, Hattori Y, Sato H, Arai T, Goto Y, Imamura Y, Sakamoto S, Ichikawa T. Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data. Cancers (Basel). 2023 Mar 7;15(6):1638.
38.	Saito S, Sakamoto S, Higuchi K, Sato K, Zhao X, Wakai K, Kanesaka M, Kamada S, Takeuchi N, Sazuka T, Imamura Y, Anzai N, Ichikawa T, Kawakami E. Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy. Sci Rep. 2023 Apr 18;13(1):6325.
39.	Komiya A, Kato M, Shibata H, Imamura Y, Sazuka T, Sakamoto S, Uchida N, Takayanagi Y, Nako Y, Tajima M, Hiraoka K, Ichikawa T, Kawai K. Results of lifestyle modification promotion and reproductive/general health check for male partners of couples seeking conception. Heliyon. 2023 Apr 5;9(4):e15203.
40.	Goto Y, Utsumi T, Maruo M, Kurozumi A, Noro T, Tanaka S, Sugawara S, Chiba K, Miyazaki K, Inoue A, Komaru A, Fukasawa S, Imamura Y, Sakamoto S, Nakatsu H, Suzuki H, Ichikawa T, Nagata M. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era. Int J Urol. 2023 Aug;30(8):659-665.
41.	Fujimoto A, Sakamoto S, Horikoshi T, Zhao X, Yamada Y, Rii J, Takeuchi N, Imamura Y, Sazuka T, Matsusaka K, Ikeda JI, Ichikawa T. Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy. Sci Rep. 2023 Jun 21;13(1):10079.
42.	Arai T, Sazuka T, Oka R, Tsukamoto R, Sato H, Goto Y, Imamura Y, Sakamoto S, Ichikawa T. Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study. Anticancer Res. 2023 Aug;43(8):3615-3621.
43.	Yamada Y, Sakamoto S, Sato K, Saito S, Kanesaka M, Rii J, Kurokawa K, Tachiwaki D, Fukui Y, Shibata H, Goto Y, Sazuka T, Imamura Y, Nakatsu H, Ichikawa T. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study. Prostate. 2023 Dec;83(16):1610-1618.
44.	Fukui Y, Yamada Y, Sakamoto S, Horikoshi T, Zhao X, Sato K, Nanba S, Kubota Y, Kanesaka M, Fujimoto A, Shibata H, Goto Y, Sazuka T, Imamura Y, Uno T, Ichikawa T. Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy. Anticancer Res. 2023 Dec;43(12):5705-5712.
45.	Rii J, Sakamoto S, Mizokami A, Xu M, Fujimoto A, Saito S, Koike H, Tamura T, Arai T, Yamada Y, Goto Y, Sazuka T, Imamura Y, Suzuki K, Kanai Y, Anzai N, Ichikawa T. L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity. Cancer Sci. 2024 Mar;115(3):937-953.
46.	Maruo M, Goto Y, Miyazaki K, Inoue A, Kurokawa K, Enomoto A, Tanaka S, Katsura S, Sugawara S, Fuse M, Chiba K, Imamura Y, Sakamoto S, Nagata M, Ichikawa T. Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon. Sci Rep. 2024 Jan 9;14(1):926.
47.	Sakamoto S, Ando K, Pae S, Zhao X, Sakai K, Sato K, Saito S, Yamada Y, Rii J, Goto Y, Sazuka T, Imamura Y, Anzai N, Akakura K, Nishio K, Ichikawa T. Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer. Anticancer Res. 2024 Feb;44(2):639-647.
48.	Kamada S, Sakamoto S, Kinoshita R, Zhao X, Kamasako T, Yamase R, Junryo R, Saito S, Sangjon P, Takei A, Yamada Y, Goto Y, Imamura Y, Iguchi T, Mizokami A, Suzuki H, Akakura K, Ichikawa T. Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. Prostate. 2024 May;84(7):636-643.
49.	Kanaoka S, Okabe A, Kanesaka M, Rahmutulla B, Fukuyo M, Seki M, Hoshii T, Sato H, Imamura Y, Sakamoto S, Ichikawa T, Kaneda A. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer. Cancer Lett. 2024 Apr 28;588:216815.

B. 総説

1.	Imamura Y, Sadar MD. Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic. Int J Urol. 2016 Aug;23(8):654-65.
2.	Sugiura M, Sato H, Kanesaka M, Imamura Y, Sakamoto S, Ichikawa T, Kaneda A. Epigenetic modifications in prostate cancer. Int J Urol. 2021 Feb;28(2):140-149.
3.	Arai T, Sazuka T, Sato H, Kato M, Kamada S, Katsura S, Seito A, Miyamoto S, Wakai K, Takeuchi N, Imamura Y, Sakamoto S, Komiya A, Ichikawa T. A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study. Int J Clin Oncol. 2022 Sep;27(9):1467-1476.
4.	Zhao X, Sakamoto S, Wei J, Pae S, Saito S, Sazuka T, Imamura Y, Anzai N, Ichikawa T. Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer. Int J Mol Sci. 2023 Mar 24;24(7):6178.
5.	Suzuki S, Takahashi N, Sugo M, Ishiwata K, Ishida A, Watanabe S, Igarashi K, Ruike Y, Naito K, Fujimoto M, Koide H, Imamura Y, Sakamoto S, Ichikawa T, Kubota Y, Wada T, Yamazaki Y, Sasano H, Ikeda JI, Tatsuno I, Yokote K. Challenges in the diagnosis of the enigmatic primary adrenal leiomyosarcoma: two case reports and review of the literature. BMC Endocr Disord. 2023 Dec 18;23(1):276.

C. 症例報告

1.	Nakamura K, Matsui K, Wakai K, Sazuka T, Imamura Y, Sakamoto S, Sekita N, Ichikawa T. Left ileal conduit: A case report. IJU Case Rep. 2019 Dec 11;3(2):33-35.
2.	Sazuka T, Fujimoto A, Sato H, Arai T, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. IJU Case Rep. 2021 Aug 16;4(6):355-358.
3.	Sato H, Sazuka T, Fujimoto A, Kagitani S, Arai T, Goto Y, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy. IJU Case Rep. 2023 Mar 19;6(3):185-189.
4.	Takeuchi N, Imamura Y, Ishiwata K, Kanesaka M, Goto Y, Sazuka T, Suzuki S, Koide H, Sakamoto S, Ichikawa T. Cushing's syndrome in pregnancy in which laparoscopic adrenalectomy was safely performed by a retroperitoneal approach. IJU Case Rep. 2023 Sep 10;6(6):415-418.
5.	Tanaka S, Goto Y, Fujimoto A, Arai T, Sato H, Sazuka T, Imamura Y, Sakamoto S, Ikeda JI, Ichikawa T. A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types. IJU Case Rep. 2023 Sep 4;6(6):410-414.
6.	Arai Y, Goto Y, Sazuka T, Fujimoto A, Sato H, Imamura Y, Sakamoto S, Ota M, Ikeda JI, Ichikawa T. A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation. IJU Case Rep. 2023 Oct 4;6(6):471-474.
7.	今村有佑,　坂本信一,　市川智彦,　副腎腫瘍に対する腹腔鏡手術　単孔式および副腎部分切除に関して,　臨床泌尿器科,　第78巻　第1号　2024年1月（6－10）